CG
PLXP

Cutler Group’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Cutler Group’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,100
Closed -$21K – 6338
2021
Q4 		$21K Buy
+4,100
New +$48.1K ﹤0.01% 3105

Other funds holding PLXP

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
SGCA
Steel Grove Capital Advisors Memphis, Tennessee $949M AUM 23.78% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Cutler Group's PLXP Position: Q3 2022 in Review

Cutler Group sold out of PLx Pharma Inc. Common Stock (PLXP) in Q3 2022, closing a stake of 11,424 shares — an estimated $27K sold.

Cutler Group first reported a position in PLXP in Q3 2021 and held it in 4 quarters. The position peaked at $243K in Q3 2021. 40 funds tracked by Wall St. Rank hold PLXP as of Q3 2022.

  • Cutler Group reported no remaining PLx Pharma Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Cutler Group sold 11,424 PLx Pharma Inc. Common Stock shares in Q3 2022, an estimated $27K.
  • Cutler Group first reported a position in PLx Pharma Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • Cutler Group's PLx Pharma Inc. Common Stock position peaked at $243K in Q3 2021.
  • 40 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.